We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$5.88B
AUM Growth
+$1.01B
Cap. Flow
+$924M
Cap. Flow %
15.72%
Top 10 Hldgs %
9.87%
Holding
605
New
228
Increased
122
Reduced
115
Closed
133

Top Buys

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$60.1M
2
CLR
CONTINENTAL RESOURCES INC.
CLR
+$53.5M
3
APD icon
Air Products & Chemicals
APD
+$52.9M
4
HDS
HD Supply Holdings, Inc.
HDS
+$50.6M
5
ALLY icon
Ally Financial
ALLY
+$49.9M

Top Sells

Rank Stock Value
1
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$61.6M
2
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
+$53.4M
3
SHPG
Shire pic
SHPG
+$51.9M
4
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$50.2M
5
BLMN icon
Bloomin' Brands
BLMN
+$42.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.61%
2 Financials 12.78%
3 Industrials 11.19%
4 Technology 9.23%
5 Consumer Discretionary 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VC icon
401
Visteon
VC
$2.78B
$988K 0.02%
+9,244
New +$892K
RMTI icon
402
Rockwell Medical
RMTI
$28.2M
$983K 0.02%
+869
New +$891K
ZSPH
403
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$959K 0.02%
23,076
-854
-4% -$33.7K
AMTD
404
DELISTED
TD Ameritrade Holding Corp
AMTD
$947K 0.02%
+26,465
New +$898K
INNL
405
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$923K 0.02%
155,571
+19,149
+14% +$133K
ABBV icon
406
AbbVie
ABBV
$435B
$884K 0.02%
+13,516
New +$852K
PSG
407
DELISTED
Performance Sports Group Ltd.
PSG
$867K 0.01%
48,215
-76,785
-61% -$1.32M
BIOA
408
CALL
DELISTED
BioAmber Inc.
BIOA
$860K 0.01%
102,454
-1,497
-1% -$13.6K
AXAS
409
DELISTED
Abraxas Petroleum Corp
AXAS
$835K 0.01%
14,197
-9,600
-40% -$706K
LOXO
410
DELISTED
Loxo Oncology, Inc
LOXO
$807K 0.01%
68,649
+18,200
+36% +$212K
SBY
411
DELISTED
Silver Bay Realty Trust Corp.
SBY
$807K 0.01%
48,741
-104,370
-68% -$1.73M
RXII
412
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$801K 0.01%
530,000
– –
PARN
413
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$790K 0.01%
190,298
-7,048
-4% -$32K
BBY icon
414
CALL
Best Buy
BBY
$17.3B
$780K 0.01%
+20,000
New +$703K
BBY icon
415
PUT
Best Buy
BBY
$17.3B
$780K 0.01%
+20,000
New +$703K
SC
416
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$770K 0.01%
+39,280
New +$721K
NGNE icon
417
Neurogene
NGNE
$712M
$764K 0.01%
5,094
-188
-4% -$26.8K
TUBE
418
DELISTED
TubeMogul, Inc.
TUBE
$761K 0.01%
33,737
-266,263
-89% -$4.3M
HCA icon
419
HCA Healthcare
HCA
$89.5B
$749K 0.01%
+10,200
New +$717K
RWT
420
Redwood Trust
RWT
$594M
$732K 0.01%
+37,168
New +$697K
EVFM
421
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$712K 0.01%
+1,057
New +$798K
NDRM
422
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$677K 0.01%
+48,215
New +$381K
ICLR icon
423
Icon
ICLR
$12.7B
$669K 0.01%
13,125
-403,396
-97% -$21.8M
ZGNX
424
DELISTED
Zogenix, Inc.
ZGNX
$669K 0.01%
+61,064
New +$605K
BHC icon
425
Bausch Health
BHC
$2.34B
$661K 0.01%
+4,619
New +$621K
15 16
17
18 19

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2014 Portfolio in Review

As of Q4 2014, Alyeska Investment Group held 605 positions worth $5.88B, up 21% from $4.86B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Alyeska Investment Group deployed $924M of net new capital in Q4 2014, opening 228 new positions and adding to 122 existing holdings. Its largest new stake was Halliburton: 1,234,449 shares worth $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Bloomin' Brands, an estimated $42.5M trimmed.

  • Alyeska Investment Group's largest Q4 2014 buy was Halliburton: 1,234,449 shares worth $48.6M.
  • Alyeska Investment Group added most to HD Supply Holdings, Inc. in Q4 2014, an estimated $50.6M increase.
  • Alyeska Investment Group's biggest Q4 2014 reduction was Bloomin' Brands, cutting an estimated $42.5M.
  • Alyeska Investment Group fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $61.6M.
  • Alyeska Investment Group's ten largest holdings make up 9.9% of its $5.88B portfolio in Q4 2014.
  • Alyeska Investment Group opened 228 new positions and closed 133 in Q4 2014.
  • Alyeska Investment Group's portfolio value rose 21% quarter-over-quarter to $5.88B.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.